Filing Flows › Wave Life Sciences (WVE) › Q2 2026 › vs Q2 2025
Wave Life Sciences (WVE) Q2 2026 vs Q2 2025 (year over year)
Wave Life Sciences's revenue fell $6.4M (-74%) from $8.7M in Q2 2025 to $2.3M in Q2 2026.
Wave Life Sciences, Q2 2026: revenue $2.3M (-74% year over year), net loss $69.4M, operating cash flow −$53.6M. The chart draws each line against Q2 2025, the increases inside each band.
Every line
| Line | Q2 2026 | Q2 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $2.3M | $8.7M | −$6.4M | -74% |
| Other income, net | $4.4M | $2.3M | $2.2M | +94% |
| Net loss | $69.4M | $50.5M | $18.9M | +37% |
| Costs & expenses | $76.1M | $61.5M | $14.6M | +24% |
| Operating costs | $76.1M | $61.5M | $14.6M | +24% |
| Research & development | $51.3M | $43.5M | $7.8M | +18% |
| General & admin | $24.8M | $18.0M | $6.8M | +38% |
| Operating cash sources | $69.4M | $50.5M | $18.9M | +37% |
| Depreciation | $858K | $865K | −$7K | -0.8% |
| Share-based compensation | $10.7M | $6.2M | $4.5M | +73% |
| Working capital & other | $4.2M | −$2.6M | $6.8M | — |
| Cash used in operations | $53.6M | $46.0M | $7.6M | +16% |
| Net loss absorbed | $69.4M | $50.5M | $18.9M | +37% |
Questions
How much did Wave Life Sciences's revenue grow year over year in Q2 2026?
Wave Life Sciences's revenue fell $6.4M (-74%) from $8.7M in Q2 2025 to $2.3M in Q2 2026.